Clinical Trials Browser

Phase 3 × Lymphoma, Non-Hodgkin × ibritumomab tiuxetan × Clear all

Lymphoma, Non-Hodgkin

NCT02366663 2018-03-12

SPINOZA

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00319332 2015-04-17

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Phase 3 Withdrawn

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT00463463 2012-07-12

Zevalin

Phase 3 Unknown

Lymphoid

Lymphoma, Non-Hodgkin

NCT00057343 2006-09-12

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Phase 3 Terminated

400 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

Clinical Trials

Zevalin-beam for Aggressive Lymphoma

SPINOZA

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Zevalin

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma